カテゴリー： QYResearch, 世界

免疫療法薬の世界市場：規模・現状・予測

◆英語タイトル：Global Immunotherapeutic Drugs Market Size, Status and Forecast 2019-2025
◆商品コード：DATA909X18559
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月25日（※2024年版があります。お問い合わせください）
◆ページ数：98
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,900 ⇒換算￥577,200	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,850 ⇒換算￥865,800	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,800 ⇒換算￥1,154,400	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、免疫療法薬の世界市場について調査・分析し、免疫療法薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（モノクローナル抗体、ワクチン、チェックポイント阻害剤、インターフェロン）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界の免疫療法薬市場動向
・主要企業別マーケットシェア
・免疫療法薬の種類別市場規模2014-2019
（モノクローナル抗体、ワクチン、チェックポイント阻害剤、インターフェロン）
・免疫療法薬の用途別市場規模2014-2019
（病院、診療所、その他）
・免疫療法薬の北米市場：主要企業・種類別/用途別市場規模
・免疫療法薬のヨーロッパ市場：主要企業・種類別/用途別市場規模
・免疫療法薬の中国市場：主要企業・種類別/用途別市場規模
・免疫療法薬の日本国内市場：主要企業・種類別/用途別市場規模
・免疫療法薬の東南アジア市場：主要企業・種類別/用途別市場規模
・免疫療法薬のインド市場：主要企業・種類別/用途別市場規模
・免疫療法薬の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Roche、Merck、Novartis、Johnson & Johnson、GlaxoSmithKline、AbbVie、ELI Lilly、Amgen、AstraZeneca、Bristol-Mysers Squibb）
・免疫療法薬の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

【レポートの概要】

Immunotherapy is a cancer treatment that enhances the body’s natural defenses against cancer-fighting tissues.In this treatment, substances made in the body or laboratory are used to improve or restore immune system function.The drugs used in this treatment are called immunotherapeutics.Immunotherapy drugs are designed to warn the immune system about mutated cells, so it can easily find and destroy them.In 2018, the global Immunotherapeutic Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Immunotherapeutic Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immunotherapeutic Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb

Market segment by Type, the product can be split into
Monoclonal Antibody
Vaccines
Checkpoint Inhibitor
Interferon

Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Immunotherapeutic Drugs status, future forecast, growth opportunity, key market and key players.
To present the Immunotherapeutic Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Immunotherapeutic Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Monoclonal Antibody
1.4.3 Vaccines
1.4.4 Checkpoint Inhibitor
1.4.5 Interferon
1.5 Market by Application
1.5.1 Global Immunotherapeutic Drugs Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Immunotherapeutic Drugs Market Size
2.2 Immunotherapeutic Drugs Growth Trends by Regions
2.2.1 Immunotherapeutic Drugs Market Size by Regions (2019-2025)
2.2.2 Immunotherapeutic Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Immunotherapeutic Drugs Market Size by by Players
3.1.1 Global Immunotherapeutic Drugs Revenue by by Players (2014-2019)
3.1.2 Global Immunotherapeutic Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Immunotherapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Immunotherapeutic Drugs Key Players Head office and Area Served
3.3 Key Players Immunotherapeutic Drugs Product/Solution/Service
3.4 Date of Enter into Immunotherapeutic Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Immunotherapeutic Drugs Market Size by Type (2014-2019)
4.2 Global Immunotherapeutic Drugs Market Size by Application (2014-2019)

5 North America
5.1 North America Immunotherapeutic Drugs Market Size (2014-2019)
5.2 Immunotherapeutic Drugs Key Players in North America
5.3 North America Immunotherapeutic Drugs Market Size by Type
5.4 North America Immunotherapeutic Drugs Market Size by Application

6 Europe
6.1 Europe Immunotherapeutic Drugs Market Size (2014-2019)
6.2 Immunotherapeutic Drugs Key Players in Europe
6.3 Europe Immunotherapeutic Drugs Market Size by Type
6.4 Europe Immunotherapeutic Drugs Market Size by Application

7 China
7.1 China Immunotherapeutic Drugs Market Size (2014-2019)
7.2 Immunotherapeutic Drugs Key Players in China
7.3 China Immunotherapeutic Drugs Market Size by Type
7.4 China Immunotherapeutic Drugs Market Size by Application

8 Japan
8.1 Japan Immunotherapeutic Drugs Market Size (2014-2019)
8.2 Immunotherapeutic Drugs Key Players in Japan
8.3 Japan Immunotherapeutic Drugs Market Size by Type
8.4 Japan Immunotherapeutic Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Immunotherapeutic Drugs Market Size (2014-2019)
9.2 Immunotherapeutic Drugs Key Players in Southeast Asia
9.3 Southeast Asia Immunotherapeutic Drugs Market Size by Type
9.4 Southeast Asia Immunotherapeutic Drugs Market Size by Application

10 India
10.1 India Immunotherapeutic Drugs Market Size (2014-2019)
10.2 Immunotherapeutic Drugs Key Players in India
10.3 India Immunotherapeutic Drugs Market Size by Type
10.4 India Immunotherapeutic Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Immunotherapeutic Drugs Market Size (2014-2019)
11.2 Immunotherapeutic Drugs Key Players in Central & South America
11.3 Central & South America Immunotherapeutic Drugs Market Size by Type
11.4 Central & South America Immunotherapeutic Drugs Market Size by Application

12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Immunotherapeutic Drugs Introduction
12.1.4 Roche Revenue in Immunotherapeutic Drugs Business (2014-2019))
12.1.5 Roche Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Immunotherapeutic Drugs Introduction
12.2.4 Merck Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.2.5 Merck Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Immunotherapeutic Drugs Introduction
12.3.4 Novartis Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Immunotherapeutic Drugs Introduction
12.4.4 Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.4.5 Johnson & Johnson Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Immunotherapeutic Drugs Introduction
12.5.4 GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.5.5 GlaxoSmithKline Recent Development
12.6 AbbVie
12.6.1 AbbVie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Immunotherapeutic Drugs Introduction
12.6.4 AbbVie Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.6.5 AbbVie Recent Development
12.7 ELI Lilly
12.7.1 ELI Lilly Company Details
12.7.2 Company Description and Business Overview
12.7.3 Immunotherapeutic Drugs Introduction
12.7.4 ELI Lilly Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.7.5 ELI Lilly Recent Development
12.8 Amgen
12.8.1 Amgen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Immunotherapeutic Drugs Introduction
12.8.4 Amgen Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.8.5 Amgen Recent Development
12.9 AstraZeneca
12.9.1 AstraZeneca Company Details
12.9.2 Company Description and Business Overview
12.9.3 Immunotherapeutic Drugs Introduction
12.9.4 AstraZeneca Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.9.5 AstraZeneca Recent Development
12.10 Bristol-Mysers Squibb
12.10.1 Bristol-Mysers Squibb Company Details
12.10.2 Company Description and Business Overview
12.10.3 Immunotherapeutic Drugs Introduction
12.10.4 Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.10.5 Bristol-Mysers Squibb Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Immunotherapeutic Drugs Key Market Segments
Table Key Players Immunotherapeutic Drugs Covered
Table Global Immunotherapeutic Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Monoclonal Antibody Figures
Table Key Players of Monoclonal Antibody
Figuer Vaccines Figures
Table Key Players of Vaccines
Figuer Checkpoint Inhibitor Figures
Table Key Players of Checkpoint Inhibitor
Figuer Interferon Figures
Table Key Players of Interferon
Table Global Immunotherapeutic Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Immunotherapeutic Drugs Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Immunotherapeutic Drugs Report Years Considered
Figure Global Immunotherapeutic Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Immunotherapeutic Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Immunotherapeutic Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Immunotherapeutic Drugs Market Share by Regions 2014-2019
Figure Global Immunotherapeutic Drugs Market Share by Regions 2014-2019
Figure Global Immunotherapeutic Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Immunotherapeutic Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Immunotherapeutic Drugs Market Share by by Players (2014-2019)
Figure Global Immunotherapeutic Drugs Market Share by by Players in 2018
Table Global Immunotherapeutic Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Immunotherapeutic Drugs Product/Solution/Service
Table Date of Enter into Immunotherapeutic Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Immunotherapeutic Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Immunotherapeutic Drugs Market Size Share by Type (2014-2019)
Figure Global Immunotherapeutic Drugs Market Size Market Share by Type (2014-2019)
Table Global Immunotherapeutic Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Immunotherapeutic Drugs Market Size Share by Application (2014-2019)
Figure Global Immunotherapeutic Drugs Market Size Market Share by Application (2014-2019)
Figure Global Immunotherapeutic Drugs Revenue Market Share by Application in 2018
Figure North America Immunotherapeutic Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Immunotherapeutic Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Immunotherapeutic Drugs Market Share (2018-2019)
Table North America Immunotherapeutic Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Immunotherapeutic Drugs Market Share by Type 2014-2019
Table North America Immunotherapeutic Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Immunotherapeutic Drugs Market Share by Application 2014-2019
Figure Europe Immunotherapeutic Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Immunotherapeutic Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Immunotherapeutic Drugs Market Share (2018-2019)
Table Europe Immunotherapeutic Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Immunotherapeutic Drugs Market Share by Type 2014-2019
Table Europe Immunotherapeutic Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Immunotherapeutic Drugs Market Share by Application 2014-2019
Figure China Immunotherapeutic Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Immunotherapeutic Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Immunotherapeutic Drugs Market Share (2018-2019)
Table China Immunotherapeutic Drugs Market Size by Type 2014-2019 (Million US$)
Table China Immunotherapeutic Drugs Market Share by Type 2014-2019
Table China Immunotherapeutic Drugs Market Size by Application 2014-2019 (Million US$)
Table China Immunotherapeutic Drugs Market Share by Application 2014-2019
Figure Japan Immunotherapeutic Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Immunotherapeutic Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Immunotherapeutic Drugs Market Share (2018-2019)
Table Japan Immunotherapeutic Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Immunotherapeutic Drugs Market Share by Type 2014-2019
Table Japan Immunotherapeutic Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Immunotherapeutic Drugs Market Share by Application 2014-2019
Figure Southeast Asia Immunotherapeutic Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Immunotherapeutic Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Immunotherapeutic Drugs Market Share (2018-2019)
Table Southeast Asia Immunotherapeutic Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Immunotherapeutic Drugs Market Share by Type 2014-2019
Table Southeast Asia Immunotherapeutic Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Immunotherapeutic Drugs Market Share by Application 2014-2019
Figure India Immunotherapeutic Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Immunotherapeutic Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Immunotherapeutic Drugs Market Share (2018-2019)
Table India Immunotherapeutic Drugs Market Size by Type 2014-2019 (Million US$)
Table India Immunotherapeutic Drugs Market Share by Type 2014-2019
Table India Immunotherapeutic Drugs Market Size by Application 2014-2019 (Million US$)
Table India Immunotherapeutic Drugs Market Share by Application 2014-2019
Figure Central & South America Immunotherapeutic Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Immunotherapeutic Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Immunotherapeutic Drugs Market Share (2018-2019)
Table Central & South America Immunotherapeutic Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Immunotherapeutic Drugs Market Share by Type 2014-2019
Table Central & South America Immunotherapeutic Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Immunotherapeutic Drugs Market Share by Application 2014-2019
Table Roche Company Details
Table Roche Revenue in Immunotherapeutic Drugs Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Immunotherapeutic Drugs Business (2014-2019)
Table Roche Recent Development
Table Merck Company Details
Table Merck Revenue in Immunotherapeutic Drugs Business 2014-2019 (Million US$)
Figure Merck Revenue Growth Rate in Immunotherapeutic Drugs Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Immunotherapeutic Drugs Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Immunotherapeutic Drugs Business (2014-2019)
Table Novartis Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Immunotherapeutic Drugs Business 2014-2019 (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Immunotherapeutic Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Immunotherapeutic Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Immunotherapeutic Drugs Business 2014-2019 (Million US$)
Figure AbbVie Revenue Growth Rate in Immunotherapeutic Drugs Business (2014-2019)
Table AbbVie Recent Development
Table ELI Lilly Company Details
Table ELI Lilly Revenue in Immunotherapeutic Drugs Business 2014-2019 (Million US$)
Figure ELI Lilly Revenue Growth Rate in Immunotherapeutic Drugs Business (2014-2019)
Table ELI Lilly Recent Development
Table Amgen Company Details
Table Amgen Revenue in Immunotherapeutic Drugs Business 2014-2019 (Million US$)
Figure Amgen Revenue Growth Rate in Immunotherapeutic Drugs Business (2014-2019)
Table Amgen Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Immunotherapeutic Drugs Business 2014-2019 (Million US$)
Figure AstraZeneca Revenue Growth Rate in Immunotherapeutic Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table Bristol-Mysers Squibb Company Details
Table Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business 2014-2019 (Million US$)
Figure Bristol-Mysers Squibb Revenue Growth Rate in Immunotherapeutic Drugs Business (2014-2019)
Table Bristol-Mysers Squibb Recent Development
Table Global Immunotherapeutic Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Immunotherapeutic Drugs Market Size Share by Regions (2019-2025)
Figure Global Immunotherapeutic Drugs Market Size Share by Regions in 2025
Figure North America Immunotherapeutic Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Immunotherapeutic Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Immunotherapeutic Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Immunotherapeutic Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Immunotherapeutic Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Immunotherapeutic Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Immunotherapeutic Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Immunotherapeutic Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Immunotherapeutic Drugs Market Size by Product (2019-2025)
Figure Global Immunotherapeutic Drugs Market Size by Product in 2025
Table Global Immunotherapeutic Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Immunotherapeutic Drugs Market Size by Application (2019-2025)
Figure Global Immunotherapeutic Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Roche、Merck、Novartis、Johnson & Johnson、GlaxoSmithKline、AbbVie、ELI Lilly、Amgen、AstraZeneca、Bristol-Mysers Squibb

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 免疫療法薬の世界市場：規模・現状・予測(Global Immunotherapeutic Drugs Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp